Report Details:
15 Companies Covered
200 Pages
Clinical Laboratory Services Market Highlights
The clinical laboratory services market refers to the industry involved in providing diagnostic testing and laboratory services for the detection, diagnosis, monitoring, and treatment of diseases and medical conditions. These services are typically performed in specialized clinical laboratories by trained professionals such as pathologists, clinical laboratory scientists, and technicians.
Segment Analysis
The global Clinical Laboratory Services Market has been segmented based Type, Application.
The clinical laboratory services market segmentation, based on type, includes biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, and genetic testing.
This is due to the rising prevalence of heart and renal diseases, the demand for biochemical laboratory testing is also escalating, as biochemical tests are of great importance in the diagnosis of heart diseases.
The clinical laboratory services market segmentation, based on application, includes independent laboratory, reference laboratory, and hospital laboratory. The hospital laboratory dominated the market in 2021 and independent laboratory is projected to be the faster-growing segment during the forecast period, 2026-2035.
Hospitals being a primary center for providing healthcare services have clinical and medical laboratories as their major departments. These laboratories operate in multiple disciplines of chemistry, microbiology, virology, hematology, histology, immunology or molecular diagnostics, and the blood bank.
Key Players
MRFR recognizes the following companies as the key players in the global Clinical Laboratory Services Market Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics (US), Spectra Laboratories, Inc. (US), Eurofins Scientific (Luxembourg), Sonic Healthcare Limited (Australia), NeoGenomics Laboratories, Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), Clinical Reference Laboratory (US), BioReference Laboratories (US), and others
Regional Analysis
The global Clinical Laboratory Services Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America clinical laboratory services market is propelling due to the rising incidences of chronic diseases, growing awareness among people regarding disease management and early diagnosis.
Moreover, growing popularity of personalized medicine in the US is projected to create lucrative growth opportunities. Further, the major countries studied are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Europe clinical laboratory services market accounts for the second-largest market share due to a government initiative to increase awareness about preventive screening, improved public and private funding for clinical laboratory test development research, and high adoption of genome-based laboratory tests.
Furthermore, the Germany clinical laboratory services market attributed to hold the largest market share, and the France clinical laboratory services market was expected the fastest growing market in the Europe region
The Asia-Pacific clinical laboratory services market is expected to grow at a steady pace from 2025 to 2035. This is owing to the increasing healthcare infrastructure, rising number of hospitals & clinical diagnostic laboratories in China and India. Moreover, China clinical laboratory services market attributed to held the largest market share, and the India clinical laboratory services market was the fastest growing market in the Asia-Pacific region.
Key Findings of the Study
- Clinical Chemistry held 53.5% of the Clinical Laboratory Services Market in 2025, anchored by metabolic and lipid panels used in chronic disease follow-up
- Genetics & Molecular Diagnostics is projected to expand at a 10.0% CAGR through 2035 as companion diagnostics win payer coverage.
- North America captured 43.6% of 2025 revenue on the strength of national reference-lab networks
- Asia-Pacific is expected to post an 8.3% CAGR, the highest of any region
- South America generated USD 14.4 billion in 2025, led by Brazil's private laboratory chains
